The SGLT2 Inhibitor Canagliflozin Prevents Increased Lipid Oxidation in the Heart following High-Fat Feeding

被引：1
|
作者：
Flores, Itzel
Shannon, Chris
Fourcaudot, Marcel
Bakewell, Terry
Norton, Luke
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-165-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
165-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A central-acting connexin inhibitor, INI-0602, prevents high-fat diet-induced feeding pattern disturbances and obesity in mice
    Sasaki, Tsutomu
    Numano, Rika
    Yokota-Hashimoto, Hiromi
    Matsui, Sho
    Kimura, Naobumi
    Takeuchi, Hideyuki
    Kitamura, Tadahiro
    MOLECULAR BRAIN, 2018, 11
  • [32] SGLT2 inhibition prevents high fat diet-induced glucose intolerance, but not weight gain, in C57BL/6 male mice
    Li, T.
    Zhu, W.
    Sun, Z.
    Rayner, C.
    Young, R.
    Wu, T.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S257 - S258
  • [33] Increased lipid metabolism and cell turnover of MiaPaCa2 cells induced by high-fat diet in an orthotopic system
    Wang, Feng
    Kumagai-Braesch, Makiko
    Herrington, Margery K.
    Larsson, Joergen
    Permert, Johan
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (08): : 1131 - 1136
  • [34] ROLE OF KETONE BODY METABOLISM IN SGLT2 INHIBITOR-MEDIATED RENOPROTECTION IN HIGH FAT DIET-FED APOE-KNOCKOUT MICE
    Tomita, Issei
    Kume, Shinji
    Yamahara, Kosuke
    Yasuda-Yamahara, Mako
    Takeda, Naoko
    Osawa, Norihisa
    Chin-Kanasaki, Masami
    Kaneko, Tatsuroh
    Pieper, Michael
    Araki, Shin-Ichi
    Maegawa, Hiroshi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 25 - 25
  • [35] The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice
    Fukuda-Tsuru, Sayaka
    Kakimoto, Tetsuhiro
    Utsumi, Hiroyuki
    Kiuchi, Satoko
    Ishii, Shinichi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723 : 207 - 215
  • [36] Hepatocyte-Specific CCN2 Gene Deletion Prevents NASH Fibrosis in a Mouse Model of High-Fat Feeding and Diabetes
    Parry, Sarah N.
    Wang, Xiaoyu
    Min, Danqing
    Lourdesamy, Jacintha S.
    Williams, Paul F.
    Leask, Andrew
    Twigg, Stephen M.
    DIABETES, 2021, 70
  • [37] An Observational Study to Evaluate Change in Dose Requirement of Standard Glucose Lowering, Lipid Lowering, and Antihypertensive Therapy Treated with SGLT2 Inhibitor (Canagliflozin) over One Year, in Fifty T2DM Patients
    Gupta, Vishal
    Teli, Vaishali
    DIABETES, 2018, 67
  • [38] [DAla2]GIP exerts beneficial metabolic actions in high fat fed mice previously exposed to the sodium glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin
    Gault, V. A.
    Millar, P. J. B.
    Pathak, V.
    Moffett, R. C.
    Pathak, N. M.
    Bjourson, A. J.
    O'Kane, M. J.
    Flatt, P. R.
    DIABETIC MEDICINE, 2016, 33 : 59 - 59
  • [39] Genetic Ablation of Calcium-independent Phospholipase A2γ Prevents Obesity and Insulin Resistance during High Fat Feeding by Mitochondrial Uncoupling and Increased Adipocyte Fatty Acid Oxidation
    Mancuso, David J.
    Sims, Harold F.
    Yang, Kui
    Kiebish, Michael A.
    Su, Xiong
    Jenkins, Christopher M.
    Guan, Shaoping
    Moon, Sung Ho
    Pietka, Terri
    Nassir, Fatiha
    Schappe, Timothy
    Moore, Kristin
    Han, Xianlin
    Abumrad, Nada A.
    Gross, Richard W.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (47) : 36495 - 36510
  • [40] Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet
    Kusakabe, T.
    Tanioka, H.
    Ebihara, K.
    Hirata, M.
    Miyamoto, L.
    Miyanaga, F.
    Hige, H.
    Aotani, D.
    Fujisawa, T.
    Masuzaki, H.
    Hosoda, K.
    Nakao, K.
    DIABETOLOGIA, 2009, 52 (04) : 675 - 683
12345